menu
    • menu

    Company profile for Aleta Biotherapeutics

    NEW Drugs in Dev: 1
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Aleta Biotherapeutics is an immuno-oncology company focused on transforming cellular therapeutics to allow a broad spectrum of cancer indications to be targeted, including currently intractable solid tumors.Aleta Bio has created a unique portfolio of multi-antigen targeting solutions for cell therapy, designed to address the critical issues of CAR-T persistence, tumor antigen loss leading to patient relapse, and tumor antigen ...
    Aleta Biotherapeutics is an immuno-oncology company focused on transforming cellular therapeutics to allow a broad spectrum of cancer indications to be targeted, including currently intractable solid tumors.Aleta Bio has created a unique portfolio of multi-antigen targeting solutions for cell therapy, designed to address the critical issues of CAR-T persistence, tumor antigen loss leading to patient relapse, and tumor antigen heterogeneity. Co-founders Paul Rennert and Roy Lobb bring extensive scientific and leadership experience in immunology, oncology and drug development to this new enterprise.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Aleta BiotherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    27 Strathmore Rd Natick, MA
    Telephone
    Telephone
    1-508-282-6370
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.aletabio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/aletabio/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Products Expo

    Natural Products Expo

    Not Confirmed

    envelop Contact Supplier

    Natural Products Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aleta and Cancer Research UK’s Centre Announce First Patient Dosed in ALETA-001
    Aleta and Cancer Research UK’s Centre Announce First Patient Dosed in ALETA-001

    21 Feb 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240221259676/en

    BUSINESSWIRE
    21 Feb 2024
    Share Share
    Aleta Granted MHRA Trial Authorization for Biologic CAR T-Cell Engager ALETA-001
    Aleta Granted MHRA Trial Authorization for Biologic CAR T-Cell Engager ALETA-001

    08 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230808939652/en

    BUSINESSWIRE
    08 Aug 2023
    Share Share
    Aleta Receives Designation for Biologic CAR T-Cell Therapy Engager ALETA-001
    Aleta Receives Designation for Biologic CAR T-Cell Therapy Engager ALETA-001

    07 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221107005927/en

    BUSINESSWIRE
    07 Nov 2022
    Share Share
    Aleta Bio Announces ALETA-001 Poster Presentation at 63rd ASH
    Aleta Bio Announces ALETA-001 Poster Presentation at 63rd ASH

    11 Dec 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211211005005/en

    BUSINESSWIRE
    11 Dec 2021
    Share Share
    Aleta Biotherapeutics Announces ALETA-001 Presentation at 63rd ASH
    Aleta Biotherapeutics Announces ALETA-001 Presentation at 63rd ASH

    09 Nov 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211109005662/en/Aleta-Biotherapeutics-Announces-ALETA-001-Presentation-at-63rd-ASH-Annual-Meeting

    BUSINESSWIRE
    09 Nov 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search